A study confirmed that hepatic RGS6 increases oxidative stress and inflammation, which drive lipid deposition, fibrosis, and nonalcoholic fatty liver disease (46). This evidence concerns the gene RGS6 and metabolic dysfunction-associated steatotic liver disease.